Keybanc Maintains Overweight on Tenet Healthcare, Lowers Price Target to $225

Benzinga Newsdesk www.benzinga.com Negative 80.6%

Neg 80.6% Neu 0% Pos 0%

Keybanc analyst Matthew Gillmor maintains Tenet Healthcare (NYSE:THC) with a Overweight and lowers the price target from $250 to $225.